For: | Arsenos P, Gatzoulis KA, Tsiachris D, Dilaveris P, Sideris S, Sotiropoulos I, Archontakis S, Antoniou CK, Kordalis A, Skiadas I, Toutouzas K, Vlachopoulos C, Tousoulis D, Tsioufis K. Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach. World J Cardiol 2022; 14(3): 139-151 [PMID: 35432775 DOI: 10.4330/wjc.v14.i3.139] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v14/i3/139.htm |
Number | Citing Articles |
1 |
Kevin Willy, Julia Köbe, Florian Reinke, Benjamin Rath, Christian Ellermann, Julian Wolfes, Felix K. Wegner, Patrick R. Leitz, Philipp S. Lange, Lars Eckardt, Gerrit Frommeyer. Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death. Journal of Personalized Medicine 2022; 12(8): 1240 doi: 10.3390/jpm12081240
|
2 |
Mohsin Khan, Arshad Jahangir. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy. Cardiology Clinics 2023; 41(4): 545 doi: 10.1016/j.ccl.2023.06.005
|
3 |
Xiaoping Xiang, Yanru Chen, Lijun Dai, Mohammad Farukh Hashmi. Effect of Perioperative Comprehensive Nursing Intervention on the Rehabilitation Effect of Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/6436073
|
4 |
Danielle Massarella, Rafael Alonso-Gonzalez. Updates in the management of congenital heart disease in adult patients. Expert Review of Cardiovascular Therapy 2022; 20(9): 719 doi: 10.1080/14779072.2022.2125870
|
5 |
Arie O. Verkerk, Ronald Wilders. The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data. Biomedicines 2023; 11(9): 2447 doi: 10.3390/biomedicines11092447
|
6 |
Natalia Przytuła, Ewa Dziewięcka, Mateusz Winiarczyk, Katarzyna Graczyk, Agnieszka Stępień, Paweł Rubiś. Hypertrophic cardiomyopathy and left ventricular non-compaction: Distinct diseases or variant phenotypes of a single condition?. World Journal of Cardiology 2024; 16(9): 496-501 doi: 10.4330/wjc.v16.i9.496
|
7 |
Petros Arsenos, Konstantinos A. Gatzoulis, Ageliki Laina, Ioannis Doundoulakis, Stergios Soulaidopoulos, Athanasios Kordalis, George Oikonomou, Konstantinos Triantafyllou, Nikolaos Fragakis, Vasillios Vasilikos, Konstantinos Tsioufis. QT interval extracted from 30-minute short resting Holter ECG recordings predicts mortality in heart failure. Journal of Electrocardiology 2022; 72: 109 doi: 10.1016/j.jelectrocard.2022.03.013
|
8 |
Mohsin Khan, Arshad Jahangir. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy. Heart Failure Clinics 2024; 20(4): 407 doi: 10.1016/j.hfc.2024.06.007
|
9 |
Petros Arsenos, Konstantinos Tsioufis, Konstantinos A Gatzoulis. Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients. European Heart Journal 2024; 45(26): 2341 doi: 10.1093/eurheartj/ehae311
|